Related Experiment Video
Updated: Mar 24, 2026

Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL
Published on: July 19, 2024
An extremely indolent T-cell leukemia: an 18-year follow-up
Samuel Adediran1, Dennis Cornfield2, Adam Bagg3
1Department of Medicine, Lehigh Valley Hospital, Allentown, Pennsylvania, USA. samuel.adediran@lvhn.org.
This case study tracks an indolent form of T-cell prolymphocytic leukemia (T-PLL) for over 18 years. The patient remained asymptomatic, highlighting the potential for long-term indolent disease course in T-PLL.
Area of Science:
- Hematology
- Oncology
Background:
- T-cell prolymphocytic leukemia (T-PLL) is a rare, aggressive lymphoid malignancy.
- T-PLL typically presents with lymphocytosis, splenomegaly, and a poor prognosis, with median survival under 1 year.
- Some T-PLL cases exhibit an indolent course before progression.
Purpose of the Study:
- To report long-term follow-up of a rare indolent T-cell prolymphocytic leukemia case.
- To observe the disease course and patient status over an extended period.
Main Methods:
- Case study with extended follow-up.
- Monitoring of patient's clinical status and symptoms related to T-cell prolymphocytic leukemia.
Main Results:
- The patient, initially diagnosed with indolent T-PLL in 1995 and reported in 2002, remained asymptomatic for an additional 11 years.
- Total follow-up extends over 18 years from initial diagnosis, with sustained lack of disease-related symptoms.
Conclusions:
- This case demonstrates the possibility of a prolonged, asymptomatic indolent phase in T-cell prolymphocytic leukemia.
- Extended follow-up is crucial for understanding the natural history of rare T-PLL variants.
More Related Videos
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018